Society of Gynecologic Oncology

Our News on Newswise
View All >

Foundation for Women's Cancer Commemorates Gynecologic Cancer Awareness Month with Vital Educational Outreach and Resourceful Toolkit

The Foundation for Women’s Cancer (FWC) recognizes September as Gynecologic Cancer Awareness Month annually, and this year is sharing an array of impactful resources aimed at raising awareness about gynecologic cancers and promoting education. FWC...
31-Aug-2023 9:05 PM EDT Add to Favorites

VIDEO

Two Clinical Trials Reveal Addition of Immunotherapy to Chemotherapy Regimen Increases Progression-Free Survival in Endometrial Cancer Patients

The results of two clinical trials, presented today at the Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer, showcased adding immunotherapy to standard chemotherapy resulted in significantly longer progression-free...
26-Mar-2023 1:00 PM EDT Add to Favorites

VIDEO

Trial’s Long-Term Follow-Up Data Shows No Difference in Overall Survival Among Ovarian Cancer Patients Who Did and Did Not Receive Parp Inhibitor Maintenance Therapy

After resolving missing data burdens, the ENGOT-OV16/NOVA (NCT01847274) study data shows no difference in overall survival for platinum-sensitive recurrent ovarian cancer (PSROC) patients who received PARP inhibitor niraparib maintenance therapy...
23-Mar-2023 6:00 AM EDT Add to Favorites

VIDEO

Gynecologic Cancer Patients Report Time-Related Burdens and Financial Toxicities Impact Quality of Life

Time-related and financial burdens are detrimental to gynecologic cancer patient and survivor quality of life (QOL), according to two research studies presented yesterday and today at the Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on...
23-Mar-2023 6:00 AM EDT Add to Favorites

VIDEO

Clinical Trial Participation Associated with Improved Overall Survival in Ovarian Cancer Patients

Clinical trial participation was associated with improved overall survival (OS) compared to standard of care therapy among women with platinum-resistant epithelial ovarian cancer (EOC), according to a research study presented today at the Society of...
23-Mar-2023 6:00 AM EDT Add to Favorites

VIDEO

Study Finds Intriguing Outcomes in Ovarian Cancer Patients Treated with PARP Inhibitors Before Surgical Intervention and Subsequent Chemotherapy

Administering PARP inhibitor (PARPi) olaparib prior to surgical intervention and chemotherapy in ovarian cancer patients – a new approach – is feasible and resulted in favorable surgical options, managed adverse events, and positive health...
23-Mar-2023 6:00 AM EDT Add to Favorites

Newswise: 6419d23fb6911_FWCgyncancersurvivoreducationcoursefriendslaughing.jpg

The Foundation for Women’s Cancer to Host Patient and Advocates Education Forum at the Society of Gynecologic Oncology Annual Meeting on Women's Cancer in Tampa on March 24

The Foundation for Women’s Cancer will host a Patients and Advocates Education Forum and Luncheon on Friday, March 24, 2023 in Tampa, FL during the Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women's Cancer.
21-Mar-2023 12:00 PM EDT Add to Favorites